Washed Microbiota Transplantation in Solid Organ Transplantation
NCT06708676 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-11-27
Summary
Solid organ transplantation (SOT), an alternative therapy for end-stage diseases, offers increased longevity and better quantity of life. Posttransplant complications such as gastrointestinal symptoms, infection, and graft rejection increase risk with graft failure and death. However, the treatment of abovementioned complications remains unsatisfactory. Gut dysbiosis has been reported in patients with SOT, especially in patients with posttransplant complications. Recipients are more susceptible to gut dysbiosis as long-term use of immunosuppressants, antibiotics and corticosteroids. Restoring gut microbiome may be a promising therapy for posttransplant complications. Washed microbiota transplantation (WMT) is a newly improved methodology of fecal microbiota transplantation based on automatic facilities, washing process and a new delivery routine. In this study, investigators aimed to evaluate the efficacy and safety of WMT for postoperative complications in SOT.
Conditions
- Solid Organ Transplant Complications
Interventions
- OTHER
-
Washed Microbiota Transplantation
Washed microbiota suspension delivered through mild-gut and lower-gut
Sponsors & Collaborators
-
The Second Hospital of Nanjing Medical University
lead OTHER
Principal Investigators
-
Faming Zhang, PhD · The Second Hospital of Nanjing Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-20
- Primary Completion
- 2029-12-31
- Completion
- 2030-12-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Auto-FMT in Preventing aGVHD
NCT04745221 ·Status: RECRUITING ·Phase: NA
-
Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients
NCT00026767 ·Status: COMPLETED
-
The Efficiency of the Central Venous Catheter Care Protocol
NCT05705895 ·Status: UNKNOWN ·Phase: NA
-
Effect of BM-MSCs in DCD Kidney Transplantation
NCT02561767 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Toxicity From Stem Cell Transplant
NCT00631787 ·Status: COMPLETED
-
Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease
NCT05152160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
NCT06143501 ·Status: RECRUITING
-
Fecal Microbiota Transplantation After HSCT
NCT02733744 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
NCT06149832 ·Status: RECRUITING ·Phase: PHASE4
-
FMT for Steroid Resistant Gut Acute GVHD
NCT04285424 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT
NCT04194840 ·Status: COMPLETED ·Phase: NA
-
Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients
NCT02463214 ·Status: COMPLETED ·Phase: NA
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study
NCT06004063 ·Status: RECRUITING ·Phase: NA
-
HBOT in the Treatment and Prevention of aGVHD
NCT05078073 ·Status: UNKNOWN ·Phase: NA
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
NCT00361049 ·Status: COMPLETED ·Phase: PHASE1
-
Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation
NCT03600896 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06949267 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT06676852 ·Status: RECRUITING ·Phase: NA
-
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
NCT04687657 ·Status: UNKNOWN ·Phase: PHASE1
-
Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients
NCT05590091 ·Status: UNKNOWN ·Phase: NA
-
MSC for Treatment of cGVHD After Allo-HSCT
NCT04692376 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of BM-MSCs on Chronic AMR After Kidney Transplantation
NCT02563340 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2